PharmaCyte Biotech, Inc. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - July 29, 2016

Attached files

file filename
EX-23.2 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - PharmaCyte Biotech, Inc.pharmacyte_10k-ex2302.htm
EX-10.37 - FIRST AMENDMENT TO LICENSING AGREEMENT - PharmaCyte Biotech, Inc.pharmacyte_10k-ex1037.htm
EX-31.1 - CERTIFICATION - PharmaCyte Biotech, Inc.pharmacyte_10k-ex3101.htm
EX-32.1 - WRITTEN STATEMENT PURSUANT TO 18 U.S.C. SECTION 1350 - PharmaCyte Biotech, Inc.pharmacyte_10k-ex3201.htm
EX-23.3 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - PharmaCyte Biotech, Inc.pharmacyte_10k-ex2303.htm
EX-21.1 - LIST OF SUBSIDIARIES - PharmaCyte Biotech, Inc.pharmacyte_10k-ex2101.htm
EX-10.38 - EX-10.38 - PharmaCyte Biotech, Inc.pharmacyte_10k-ex1038.htm
EX-10.36 - VARIATION TO LICENSE AGREEMENT - PharmaCyte Biotech, Inc.pharmacyte_10k-ex1036.htm
EX-10.31 - SECOND AMENDMENT TO LICENSING AGREEMENT - PharmaCyte Biotech, Inc.pharmacyte_10k-ex1031.htm
EX-10.30 - FIRST AMENDMENT TO LICENSING AGREEMENT - PharmaCyte Biotech, Inc.pharmacyte_10k-ex1030.htm
10-K - FORM 10-K - PharmaCyte Biotech, Inc.pharmacyte_10k-043016.htm

EXHIBIT 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

PharmaCyte Biotech, Inc.

(Formerly Nuvilex, Inc.)

Silver Spring, Maryland

 

We hereby consent to the incorporation by reference in the Registration Statement on Amendment No. 1 to Form S-3 (No. 333-199440) of PharmaCyte Biotech, Inc., formerly Nuvilex, Inc. (“Company”), relating to the consolidated financial statements and schedule as of April 30, 2016 for the year ended April 30, 2016, which appears in this Form 10-K.

 

/s/ Armanino LLP

Certified Public Accountants

San Ramon, California

July 29, 2016

 

 

PharmaCyte Biotech, Inc. Reports